United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$100Kraised across 2 rounds since 2015, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Keiretsu Forum
Ben Franklin Technology Partners
Ben Franklin Technology Partners of Southeastern Pennsylvania
Keiretsu CapitalSource recorded
From the SEC filings it signed: 2 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Atrin Pharmaceuticals's investors include Ben Franklin Technology Partners, Keiretsu Forum, Ben Franklin Technology Partners of Southeastern Pennsylvania, Keiretsu Capital and National Cancer Institute (NCI).
Atrin Pharmaceuticals has raised $100K across 2 rounds since 2015. One round did not disclose an amount, so the total is a floor.
Atrin Pharmaceuticals's most recent round was a Venture in Jul 2022.
Atrin Pharmaceuticals's largest round on record is $100K (Seed), in Mar 2015.
Atrin Pharmaceuticals's first round on record, in Mar 2015, was backed by Ben Franklin Technology Partners.
Atrin Pharmaceuticals's latest named round is a Venture, in Jul 2022.
Atrin Pharmaceuticals is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
